BLUE - Bluebird Bio Inc. (BLUE) CEO Nick Leschly on Q2 2021 Results - Earnings Call Transcript
Bluebird Bio, Inc. (BLUE) Q2 2021 Earnings Conference Call August 09, 2021, 08:00 AM ET Company Participants Nick Leschly – Chief Executive Officer Elizabeth Pingpank – Direct Investor Relations Andrew Obenshain – President Severe Genetic Diseases Philip Gregory – Chief Scientific Officer William Denise Baird – Chief Financial Officer Conference Call Participants Salvesen Richter – Goldman Sachs Mani Foroohar – SVB Yaron Werber – Cowen Difei Yang – Mizuho Securities Charlie Ang – Morgan Stanley Dane Leone – Raymond James Gena Wang – Barclays Jason Gerberry – Bank of America Matthew Luchini – BMO Capital Mark Breidenbach – Oppenheimer Raju Prasad – William Blair Luca Issi – RBC Presentation Operator Good day and thank you for standing by. Welcome to the Bluebird Bio Second Quarter 2021 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To
For further details see:
Bluebird Bio, Inc. (BLUE) CEO Nick Leschly on Q2 2021 Results - Earnings Call Transcript